Recent Finacing
Recent Raise
Talphera develops Niyad, a lyophilized nafamostat anticoagulant for extracorporeal circuits (IDE, FDA Breakthrough Device Designation), and in‑licenses prefilled syringes Fedsyra and PFS‑02.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
